Advertisement
Dr. Paul Richardson has joined ProGenTech as its Vice President for R&Dbased in Emeryville, CA. Dr. Richardson will lead the global R&D programs andhave accountability for the company's assay development and reagent solutions.Dr. Richardson was previously the head of R&D at the DOE's Joint GenomeInstitute where for the past ten years he had led the advanced research teamssupporting the human genome project as well as the microbial genomeinitiatives and other model organism programs. Dr. Richardson brings a wealthof life science knowledge to the company.
Advertisement
Dr. Jesus Ching has been appointed the Chief Scientist for ProGenTech andwill be based in Emeryville, CA. Dr. Ching was a founder of ProGenTech and hasbeen instrumental in the design and development in the products to date. Dr.Ching will have accountability for the external scientific programs as well asour technical lead on business development activities. Dr. Ching waspreviously the director of R&D at Cepheid and brings deep knowledge andexperience in integrated systems and diagnostic platforms.
Sarah Wenning has joined ProGenTech as its Vice President of USoperations, based in Emeryville CA. Ms. Wenning will have accountability forall US programs. She was previously the deputy associate director foroperations of Lawrence Livermore National Laboratory's Biosciences Directorateand has held a number of senior management roles within Lawrence Livermore forthe past ten years. Sarah brings significant operational expertise to thecompany.
Dylan Bird has joined ProGenTech as its Director of Business Development,based in Emeryville, CA. Mr. Bird will have accountability for global strategyand business development activities. Prior to joining ProGenTech, Mr. Bird wasan investment professional at Bay City Capital, one of the two VC's that werepart of the recently announced Series C financing.
David Hu has joined ProGenTech as its Vice President of Engineering, basedin Shanghai. Mr Hu will have accountability for all engineering programs andnew system development and commercialization. David will work closely withPaul Richardson to define our new product roadmaps. David was the lead Angelinvestor for ProGenTech and remains a member of the ProGenTech board. Davidhas made a career as an entrepreneur and has successfully started, capitalizedand sold several businesses in the consumer electronics field.
Commenting on the new team, Dr Trevor Hawkins, ProGenTech Chairman and CEOsaid "we have built a first class team that truly understands this market andmost importantly our customers. We now have deep experience in life sciences,clinical diagnostics and systems engineering." Steve Yu, ProGenTech Presidentand COO said "with the additional executive members coming on board,ProGenTech is now well positioned to penetrate the life science and moleculardiagnostic market with our leading technologies"
About ProGenTech
ProGenTech is a life science company based in Shanghai, Suzhou andEmeryville California.
Established in 2005, the company has 40 employees today. Their firstproduct, the Entura, was launched in Asia in November 2007. Additionalinformation about ProGenTech can be found at www.progentech.com.
SOURCE ProGenTech Limited
